Tonix Pharmaceuticals Prices Underwritten Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Tonix Pharmaceuticals (TNXP) Prices 2.33M Common Stock Offering at $7.50/Share
July 14, 2015 8:35 AM EDTTonix Pharmaceuticals (NASDAQ: TNXP) announced the pricing of an underwritten public offering of 2,325,000 shares of its common stock at a price of $7.50 per share. The company has also granted to the underwriters a 45-day option to acquire an additional 348,750 shares to cover overallotments... More
